Benchmark of BINN, GraphPath, and PATH on 2622 TCGA patients shows PATH best for targeted therapy, BINN for survival, none useful for radiation, with GraphPath at 0.92 AUROC on prostate targeted therapy.
Title resolution pending
2 Pith papers cite this work. Polarity classification is still indexing.
2
Pith papers citing it
representative citing papers
hEFS uses subsampling and multi-model voting with Pareto front selection to produce fewer, more stable prognostic biomarkers from pancreatic cancer multi-omics data while matching CoxLasso discrimination performance.
citing papers explorer
-
TRAPS: Therapeutic Response Analysis via Pathway-informed Stratification
Benchmark of BINN, GraphPath, and PATH on 2622 TCGA patients shows PATH best for targeted therapy, BINN for survival, none useful for radiation, with GraphPath at 0.92 AUROC on prostate targeted therapy.
-
Optimizing Prognostic Biomarker Discovery in Pancreatic Cancer Through Hybrid Ensemble Feature Selection and Multi-Omics Data
hEFS uses subsampling and multi-model voting with Pareto front selection to produce fewer, more stable prognostic biomarkers from pancreatic cancer multi-omics data while matching CoxLasso discrimination performance.